What is the recommended management of inter‑ictal and post‑ictal psychosis in a patient with refractory epilepsy who is being treated with vagus nerve stimulation (VNS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Inter-ictal and Post-ictal Psychosis in VNS-Treated Refractory Epilepsy

Treat psychotic symptoms promptly with low-dose atypical antipsychotics or benzodiazepines while maintaining the current antiepileptic regimen, as these medications do not significantly increase seizure risk when epilepsy is adequately controlled. 1

Immediate Symptomatic Management

The primary approach is early symptomatic treatment of psychotic symptoms, following the same principles used for primary psychotic disorders. Antipsychotics and benzodiazepines are the recommended first-line treatments for both postictal and brief interictal psychoses in epilepsy patients. 1 Clinical experience demonstrates that low doses of antipsychotic medications pose minimal seizure risk when patients are on an efficacious antiepileptic regimen 1.

Key Treatment Principles:

  • Start with low-dose atypical antipsychotics as first-line agents
  • Consider benzodiazepines as alternative or adjunctive therapy
  • Maintain aggressive seizure control with current antiepileptic drugs
  • Do not discontinue or reduce VNS therapy

VNS-Specific Considerations

Psychotic symptoms can emerge following VNS implantation, but this does not necessitate device removal or parameter adjustment. 2 Four documented cases showed psychotic symptoms after VNS initiation, likely related to VNS effects on alertness, cognition, and mood rather than traditional "forced normalization" 2. The mechanism may involve VNS-induced changes in cerebral activity patterns rather than simply improved seizure control.

Important Caveats:

  • VNS has beneficial effects on cognition and mood that should be preserved 3
  • Psychosis emergence does not indicate VNS failure or contraindication
  • The relationship between VNS and psychosis is complex and not fully understood 2

Antiepileptic Drug Optimization

Reevaluate the entire antiepileptic drug regimen before attributing psychosis solely to VNS. 1 This includes:

  • Assessing current seizure control adequacy
  • Reviewing specific antiepileptic agents being used
  • Considering drug interactions and polypharmacy effects

The concept of "alternating psychosis" (reciprocal relationship between psychosis and seizures) is linked to neurobiological mechanisms of seizure control rather than being drug-specific 1.

Psychiatric Medication Strategy

For interictal chronic psychosis specifically, consider a broader approach:

  • Combine antidepressants with mood stabilizers and/or atypical antipsychotics 4
  • Antidepressants play a more prominent role in epilepsy-related chronic psychosis compared to general psychiatric practice 4
  • Double antidepressant strategies may be appropriate in treatment-refractory cases 4

Critical Pitfalls to Avoid

  1. Do not reduce seizure control in attempt to treat psychosis - maintaining efficacious antiepileptic therapy is essential for safe antipsychotic use 1

  2. Do not assume VNS must be discontinued - psychotic symptoms can be managed while preserving VNS benefits 2

  3. Do not delay psychiatric treatment - early intervention with psychotropic medications is crucial 1

  4. Do not use typical antipsychotics preferentially - atypical agents are preferred due to better side effect profiles

Evidence Limitations

The evidence base consists primarily of case series and expert opinion rather than randomized controlled trials 1, 4. However, the consistent recommendation across multiple sources supports the safety and efficacy of low-dose antipsychotics in this population when seizures are adequately controlled.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.